Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome

Purpose Metabolic syndrome (MetS), which is a global public health problem, is a state of chronic low-grade inflammation. This study looked at the changes in hematological parameters and the predictive value of the lymphocyte to high-density lipoprotein cholesterol (HDL-C) ratio (LHR) as a new index in subjects with and without MetS in coastal cities in southern China. Patients and methods In this cross-sectional study, there were 852 participants (n = 598 with MetS and n = 254 without MetS). MetS was defined in accordance with the National Cholesterol Education Program, Adult Treatment Panel III (NCEP-ATP III) criteria. Results MetS was positively correlated with white blood cell count, total lymphocyte count, neutrophil count, red blood cell count, hematocrit, hemoglobin, and high-sensitivity C-reactive protein levels (p<0.05). In addition, there was a positive correlation between LHR and the number of metabolic risk factors for MetS. In a logistic regression analysis, LHR (odds ratio: 4.117; 95% CI: 2.766-6.309; p<0.001) was an independent predictor of MetS. When a receiver operating characteristic (ROC) curve analysis was used to assess the value of LHR for predicting MetS, the area under the curve yielded a cut-off value of 1.657, with a sensitivity of 65% and a specificity of 64% (p<0.0001). Conclusion In summary, MetS can involve changes in blood parameters, and LHR may be a useful marker of inflammation to assess the presence and severity of MetS.

[1]  B. Adams-Huet,et al.  The neutrophil count is superior to the neutrophil/lymphocyte ratio as a biomarker of inflammation in nascent metabolic syndrome , 2019, Annals of clinical biochemistry.

[2]  M. Melku,et al.  The Role of Neutrophil to Lymphocyte Count Ratio in the Differential Diagnosis of Pulmonary Tuberculosis and Bacterial Community-Acquired Pneumonia: a Cross-Sectional Study at Ayder and Mekelle Hospitals, Ethiopia. , 2019, Clinical laboratory.

[3]  M. Saklayen.  The Global Epidemic of the Metabolic Syndrome , 2018, Current Hypertension Reports.

[4]  H. Yang,et al.  Positive association between the metabolic syndrome and white blood cell counts in Chinese. , 2017, Asia Pacific journal of clinical nutrition.

[5]  Mariela Glandt,et al.  Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature , 2016, Gastroenterology research.

[6]  B. Gao,et al.  Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome , 2016, Postgraduate medicine.

[7]  Hyoung-Ji Lim,et al.  The association between platelet count and metabolic syndrome in children and adolescents , 2015, Platelets.

[8]  Anand Rohatgi.  High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity. , 2015, Progress in cardiovascular diseases.

[9]  B. Geckinli,et al.  DNA damage is increased in lymphocytes of patients with metabolic syndrome. , 2015, Mutation research. Genetic toxicology and environmental mutagenesis.

[10]  F. Xue,et al.  Association between erythrocyte parameters and metabolic syndrome in urban Han Chinese: a longitudinal cohort study , 2013, BMC Public Health.

[11]  K. Kohara,et al.  Hematological parameters are associated with metabolic syndrome in Japanese community-dwelling persons , 2013, Endocrine.

[12]  F. Xue,et al.  Association between Leukocyte and Metabolic Syndrome in Urban Han Chinese: A Longitudinal Cohort Study , 2012, PloS one.

[13]  Michelle A. Williams,et al.  Hematological parameters and metabolic syndrome: findings from an occupational cohort in Ethiopia. , 2012, Diabetes & metabolic syndrome.

[14]  E. Oda.  Metabolic syndrome: its history, mechanisms, and limitations , 2012, Acta Diabetologica.

[15]  Masayuki Yoshida,et al.  Adipose Inflammation Initiates Recruitment of Leukocytes to Mouse Femoral Artery: Role of Adipo-Vascular Axis in Chronic Inflammation , 2011, PloS one.

[16]  J. Friedman,et al.  Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide. , 2011, American journal of physiology. Heart and circulatory physiology.

[17]  E. Porteri,et al.  Intracellular molecular effects of insulin resistance in patients with metabolic syndrome , 2010, Cardiovascular diabetology.

[18]  S. Srinivasan,et al.  Black-White Divergence in the Relation of White Blood Cell Count to Metabolic Syndrome in Preadolescents, Adolescents, and Young Adults: The Bogalusa Heart Study , 2010, Diabetes Care.

[19]  A. Czech,et al.  Investigations of cellular glucose transport and its regulation under the influence of insulin in human peripheral blood lymphocytes. , 2010, Endokrynologia Polska.

[20]  V. Bourlier,et al.  Interplay Between Human Adipocytes and T Lymphocytes in Obesity: CCL20 as an Adipochemokine and T Lymphocytes as Lipogenic Modulators , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[21]  Peymane Adab,et al.  White blood cell count and the metabolic syndrome in older Chinese: the Guangzhou Biobank Cohort Study. , 2008, Atherosclerosis.

[22]  P. Libby,et al.  Adiponectin Inhibits the Production of CXC Receptor 3 Chemokine Ligands in Macrophages and Reduces T-Lymphocyte Recruitment in Atherogenesis , 2008, Circulation research.

[23]  J. Pankow,et al.  Blood Viscosity and Hematocrit as Risk Factors for Type 2 Diabetes Mellitus The Atherosclerosis Risk in Communities ( ARIC ) Study , 2008 .

[24]  Frankie B. Stentz,et al.  Transcriptome and Proteome Expressions Involved in Insulin Resistance in Muscle and Activated T-Lymphocytes of Patients with Type 2 Diabetes , 2008, Genom. Proteom. Bioinform..

[25]  T. Dusek,et al.  Pathophysiology of Metabolic Syndrome , 2007, EJIFCC.

[26]  J. A. Kim,et al.  Association of metabolic syndrome with white blood cell subtype and red blood cells. , 2006, Endocrine journal.

[27]  A. Shirom,et al.  Increased erythropoiesis and subclinical inflammation as part of the metabolic syndrome. , 2005, Diabetes research and clinical practice.

[28]  Shih-Yi Lin,et al.  Association between hematological parameters and metabolic syndrome components in a Chinese population. , 2004, Journal of diabetes and its complications.

[29]  K. Suzuki,et al.  Haematocrit and risk of development of Type 2 diabetes mellitus in middle‐aged Japanese men , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[30]  A. Nakata,et al.  Association of lymphocyte sub-populations with clustered features of metabolic syndrome in middle-aged Japanese men. , 2004, Atherosclerosis.

[31]  R. Klein,et al.  Relationship between white blood cell count and incident hypertension , 2004 .

[32]  K. Suzuki,et al.  White blood cell count and clustered features of metabolic syndrome in Japanese male office workers. , 2002, Occupational medicine.

[33]  G. Reaven,et al.  Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. , 1998, Metabolism: clinical and experimental.

[34]  S. Koury,et al.  Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. , 1989, The Journal of clinical investigation.

[35]  N. Dainiak,et al.  Interactions of insulin, insulinlike growth factor II, and platelet-derived growth factor in erythropoietic culture. , 1985, The Journal of clinical investigation.

[36]  J. Groopman,et al.  Natural and biosynthetic insulin stimulates the growth of human erythroid progenitors in vitro. , 1982, The Journal of clinical endocrinology and metabolism.

[37]  W. Oh,et al.  Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic rhesus fetuses. , 1981, The Journal of clinical investigation.